Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...